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Abstract
Introduction:  Tumors  of  the  lip  and  oral  cavity  differ  in  various  aspects;  therefore  a  clariﬁcation
of the  distinctions  among  these  sites  may  help  to  better  understand  the  biologic  behavior  of
neoplasms  occurring  in  these  locations.
Objective:  Considering  that  angiogenesis  and  lymphangiogenesis  are  two  major  elements  that
can inﬂuence  various  aspects  of  tumor  biology,  we  aimed  to  compare  these  factors  between
squamous cell  carcinoma  of  the  lower  lip  and  oral  cavity.
Methods:  A  total  of  84  primary  squamous  cell  carcinomas  including  45  oral  and  39  lower  lip
tumors were  selected  and  immunohistochemically  stained  with  monoclonal  antibody  against
D2-40 and  CD105.  Mean  microvessel  density  was  assessed  in  tumoral  tissue,  while  lymphatic
vessel density  was  calculated  in  both  neoplastic  tissue  and  invasion  front.  Data  were  statistically
analyzed  using  t-test  and  p-values  of  <0.05  were  considered  signiﬁcant.
Results:  We  found  a  mean  microvessel  density  ±  standard  deviation  of  31.94  ±  18.9  in  oral  cavity
and 27.54  ±  20.8  in  lower  lip  squamous  cell  carcinomas,  with  no  signiﬁcant  difference  (p  =  0.32).
Mean lymphatic  vessel  density  ±  standard  deviation  was  13.05  ±  8.2  and  16.57  ±  10.79  in  of  oral
cavity and  lower  lip  neoplastic  tissue,  respectively.  The  corresponding  values  were  9.94  ±  5.59
and 12.50  ±  7.8  in  the  invasive  front.  Signiﬁcant  differences  were  not  observed  in  either  of  the
lymphatic  vessel  density  variables  between  the  two  sites.
Conclusion:  According  to  our  results,  it  seems  that  the  search  for  additional  factors  other  than
those related  to  the  vasculature  should  continue,  to  help  clarify  the  differences  in  biologic
behavior between  lower  lip  and  oral  cavity  squamous  cell  carcinomas.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
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Linfangiogênese  e  angiogênese  em  carcinomas  de  células  escamosas  de  lábio  inferior
e  da  cavidade  oral
Resumo
Introduc¸ão:  Os  tumores  de  lábio  e  da  cavidade  oral  diferem  em  vários  aspectos;  portanto,  o
conhecimento  das  diferenc¸as  entre  eles  pode  ajudar  na  melhor  compreensão  do  comportamento
biológico  das  neoplasias  que  ocorrem  nesses  locais.
Objetivo:  Considerando  que  a  angiogênese  e  a  linfangiogênese  são  dois  elementos  importantes
que podem  inﬂuenciar  diversos  aspectos  da  biologia  dos  tumores,  objetivamos  comparar  esses
fatores entre  o  carcinoma  de  células  escamosas  (CCE)  de  lábio  inferior  e  da  cavidade  oral.
Método: No  total,  foram  selecionados  84  CCEs  primários  (45  tumores  da  cavidade  oral  e  39
tumores de  lábio).  Esses  tumores  foram  corados  por  processo  imuno-histoquímico  com  anti-
corpo monoclonal  anti-D2-40  e  CD105.  Avaliamos  a  densidade  média  de  microvasos  (DMV)  no
tecido tumoral,  enquanto  que  a  densidade  vascular  linfática  (DVL)  foi  calculada  tanto  no  tecido
neoplásico  como  no  front  de  invasão.  Os  dados  foram  estatisticamente  analisados  com  o  uso  do
teste t  e  valores  de  p  <  0,05  foram  considerados  signiﬁcantes.
Resultados:  Chegamos  a  uma  média  para  DMV  ±  DP  de  31,94  ±  18,9  para  CCEs  na  cavidade  oral  e
de 27,54  ±  20,8  no  lábio  inferior,  sem  diferenc¸a  signiﬁcante  (p  =  0,32).  As  médias  para  DVL  ±  DP
foram de  13,05  ±  8,2  e  16,57  ±  10,79  no  tecido  neoplásico  da  cavidade  oral  e  lábio  inferior,
respectivamente.  Os  valores  correspondentes  foram  9,94  ±  5,59  e  12,50  ±  7,8  no  front  invasivo.
Não foram  observadas  diferenc¸as  signiﬁcantes  nas  duas  variáveis  DVL  entre  os  dois  locais.
Conclusão:  De  acordo  com  os  nossos  resultados,  a  pesquisa  por  fatores  adicionais,  além  daque-
les relacionados  à  vasculatura,  deve  ter  continuidade,  para  auxiliar  no  esclarecimento  das
diferenc¸as do  comportamento  biológico  entre  CCEs  no  lábio  inferior  e  na  cavidade  oral.
© 2015  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
I
S
c
o
o
a
t
l
a
S
i
t
i
u
h
t
a
i
n
r
a
t
a
h
h
m
i
1
o
o
r
s
D
i
w
m
n
a
l
v
g
o
p
p
u
v
w
l
p
s
o
antroduction
quamous  cell  carcinomas  (SCCs)  originate  from  epithelial
ells  of  various  organs  and  their  biologic  behavior  depends
n  different  factors,  one  of  which  is  the  anatomic  location
f  the  tumor.1 A  good  example  of  this  fact  is  the  consider-
ble  etiologic  and  prognostic  differences  between  SCCs  of
he  lip  and  oral  cavity,  with  lip  neoplasms  demonstrating  a
ower  tendency  toward  regional  lymph-node  metastasis  and
 higher  survival  rate  of  approximately  90%.2,3
Many  factors  are  involved  in  the  etiopathogenesis  of
CC.  Contrary  to  SCC  of  the  oral  cavity  where  tobacco  use
s  the  most  well-known  etiologic  factor,  chronic  exposure
o  sunlight  has  been  suggested  as  an  important  element
n  SCC  of  the  lower  lip,  which  is  known  to  receive  more
ltraviolet  radiation  than  the  upper  lip.2,4,5 Recent  studies
ave  shown  that  the  expression  of  some  markers  related
o  tumor  microenvironment  and  neoplastic  cells  of  lip  SCCs
re  different  from  those  of  the  oral  cavity.2,3 Therefore,
t  seems  that  the  differences  between  these  sites  are
ot  limited  to  etiology  and  prognosis,  but  may  also  be
elated  to  molecular  factors  associated  with  their  stroma
nd  cellular  structures.2,3 Consequently,  a  number  of  inves-
igators  believe  that  SCC  of  the  lip  should  be  regarded  as
 separate  entity  and  be  evaluated  as  such.  On  the  other
and,  some  cellular-molecular  studies  on  these  locations
ave  not  shown  any  biological  difference  in  the  evaluated
arkers.6,7
Angiogenesis  is  an  important  and  fundamental  process
n  the  progression  and  metastasis  of  malignancies.  Before
l
w
e960,  researchers  believed  that  nutrition  and  blood  supply
f  neoplastic  tissues  were  simply  provided  through  dilation
f  blood  vessels  available  in  the  tumor.  Subsequent  studies
evealed  that  angiogenesis,  the  formation  of  new  blood  ves-
els,  is  vital  to  the  growth  and  propagation  of  malignancies.8
evelopment  of  a  network  of  new  blood  vessels  in  the  tumor
s  essential  to  provide  nutrients  and  oxygen  and  remove
aste  products.  For  the  initiation  of  angiogenesis,  various
olecules  are  released  from  malignant  cells,  which  send  sig-
als  to  the  surrounding  host  tissues.  This  may  result  in  the
ctivation  of  certain  genes,  followed  by  protein  production,
eading  to  the  induction  of  angiogenesis.9,10
Lymphangiogenesis  is  the  formation  of  new  lymphatic
essels  from  pre-existing  vasculature  and  similar  to  angio-
enesis  has  several  induction  mechanisms.11 The  growth
f  lymphatic  vessels  occurs  in  a  variety  of  normal  and
athologic  processes  like  wound  healing,  inﬂammation,  and
rogression  of  malignancies.12,13
SCC  of  the  oral  cavity  and  lip  have  been  separately  eval-
ated  in  terms  of  angiogenesis  and  lymphangiogenesis,  and
arious  reports  exist  on  the  association  of  these  processes
ith  the  prognosis  and  invasion  of  SCC.14--16 However,  a
imited  number  of  studies  with  conﬂicting  results  have  com-
ared  angiogenesis  and  lymphangiogenesis  between  these
ites.17,18 It  is  noteworthy  that  in  these  investigations,  SCC
f  both  upper  and  lower  lips  have  been  grouped  together
nd  evaluated  as  a  single  entity.  Considering  that  the  lower
ip  SCC  has  not  been  exclusively  evaluated  in  comparison
ith  SCC  of  the  oral  cavity  and  the  important  differ-
nces  between  upper  and  lower  lip  tumors,19 we  aimed  to
r  lip  SCC  387
Figure  1  Representative  section  of  lymphatic  vessel  density
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separately  in  the  neoplastic  tissue  and  tumor  invasive  front
(Fig.  1),  while  MVD  was  assessed  generally  in  the  SCC  tissues
(Fig.  2).Lymphangiogenesis  and  angiogenesis  in  oral  cavity  and  lowe
compare  angiogenesis  and  lymphangiogenesis  between
lower  lip  and  oral  cavity  SCC  using  CD105  and  D2-40  markers.
Methods
Samples
This  retrospective  study  was  performed  on  individuals  with
primary  SCC  who  were  consecutively  visited  at  the  Can-
cer  Institute  of  Imam  Khomeini  Hospital  Complex,  afﬁliated
with  Tehran  University  of  Medical  Sciences  between  2007
and  2012,  using  the  patient  record  archive  of  this  Center.
Cases  which  had  a  history  of  chemotherapy,  radiotherapy,
or  any  other  treatment  prior  to  surgery  were  not  included  in
this  work.  Excisional  biopsy  samples  with  signiﬁcant  necro-
sis  and  inadequate  tissue  were  also  excluded  from  the  study.
Age  and  sex  were  recorded  for  each  subject  according  to  the
clinical  data  provided  in  their  medical  charts.  Formalin-ﬁxed
parafﬁn  blocks  of  all  lesions  corresponding  to  the  patient
charts  of  the  selected  cases  were  retrieved  from  the  pathol-
ogy  archive  to  be  used  for  immunohistochemical  analysis.
This  project  was  approved  by  the  ethics  committee  of  Tehran
University  of  Medical  Sciences  (code  n◦ 70-10646).
Immunohistochemical  staining
Formalin-ﬁxed  parafﬁn-embedded  tissue  sections  (3  m)
were  mounted  on  poly-l-lysine-coated  slides  and  subjected
to  deparafﬁnization  in  xylene,  followed  by  rehydration  in
graded  alcohol  and  antigen  retrieval.  For  D2-40,  this  was
done  by  immersing  the  specimens  in  citrate  buffer  (0.1  M,
pH  6)  and  heating  in  a  microwave  oven  for  2  cycles  of
15  min  each,  and  for  CD105  pretreatment  with  proteinase  K
was  performed  for  5  min.  Endogenous  peroxidase  was  then
blocked  by  incubating  the  sections  in  a  solution  of  3%  hydro-
gen  peroxide  and  methanol  for  half  an  hour.  After  washing
with  Tris-buffered  saline  (TBS),  the  specimens  were  treated
with  either  D2-40  (D2-40,  Dako  Cytomation)  or  CD105  (SN6h,
Dako,  Glostrup,  Denmark)  monoclonal  antibodies  for  1  h
in  a  humid  chamber  at  1:1000  and  1:30  dilutions,  respec-
tively.  TBS  was  used  for  rinsing  before  incubating  with
EnVision  System  (Dako  Cytomation,  Glostrup,  Denmark)  at
room  temperature  for  30  min.  Antigen--antibody  reaction
was  visualized  with  diaminobenzidine,  and  counterstaining
was  carried  out  with  Mayer’s  hematoxylin.  Positive  controls
consisting  of  breast  carcinoma  with  known  immunoreac-
tions  for  D2-40  and  normal  liver  tissue  for  CD105  along  with
negative  controls  (omission  of  primary  antibody  for  nega-
tive  control)  were  run  simultaneously  with  the  experimental
slides.
Staining  evaluation
Microvessel  density  (MVD)  and  lymphatic  vessel  density
(LVD)  were  quantiﬁed  according  to  the  method  described
previously.20 In  brief,  using  a  double-headed  microscope
(Olympus  BH2,  Tokyo,  Japan),  ﬁve  hotspots  were  selected
at  100×  magniﬁcation  by  two  oral  pathologists,  followed  by
microvessel  counting  at  400× (ﬁeld  size:  0.18  mm2)  and  cal-
culating  the  mean  microvessel  count  for  each  sample.  Any
possible  disagreements  were  resolved  by  consensus.
F
i
nsing immunohistochemistry  with  monoclonal  antibody  against
2-40 (original  magniﬁcation  200×).
tatistical  analysis
tatistical  analysis  was  performed  using  t-test,  and  p  <  0.05
as  considered  signiﬁcant.
esults
e  obtained  a  total  of  84  cases  of  SCC,  45  of  which  were
ocated  in  the  oral  cavity  and  39  in  the  lower  lip.  Of  the  39
ower  lip  SCC  samples,  5  (13.5%)  were  female  and  34  (86.5%)
ere  male,  corresponding  to  31  (68.9%)  male  and  14  (31.1%)
emale  patients  with  SCC  of  the  oral  cavity.  The  age  range
f  the  patients  with  lower  lip  and  oral  cavity  SCC  was  31--90
mean:  65)  and  19--64  (mean:  61)  years,  respectively.  Oral
avity  tumors  were  located  in  the  tongue  (21:  46.7%),  ﬂoor
f  the  mouth  (8:  17.8%),  buccal  mucosa  (6:  13.3%),  gingiva
6:  13.3%)  and  maxilla  (4:  8.9%).
Immunohistochemical  evaluation  of  LVD  was  performedigure  2  Microvessel  density  showing  newly  formed  vessels
mmunostained  with  monoclonal  antibody  against  CD105  (origi-
al magniﬁcation  200×).
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Table  1  Comparison  of  microvessel-  and  lymphatic  vessel-density  in  oral  cavity  and  lower  lip  SCC.
Sex/age  No  (%)  MVDa p  value  Tumoral  LVDb p  value  Invasive
margin  LVD
p  value
Oral  cavity
SCC
Male  31  (68.9)  34.23  ±  16.13 0.254 10.56  ±  5.73 0.527 12.72  ±  8.27 0.734
Female 14  (31.1)  27.61  ±  17.53  9.30  ±  5.74  13.69  ±  8.18
<60 years  17  (37.8)  30.95  ±  15.33 0.685 9.68  ±  5.85 0.935 12.33  ±  9.05 0.958
≥60 years  28  (62.2)  33.28  ±  17.95  10.34  ±  5.87  12.47  ±  7.74
Lower lip
SCC
Male  34  (86.5)  26.91  ±  20.82 0.422 12.15  ±  8.86 0.392 16.46  ±  11.17 0.391
Female 5  (13.5)  37.53  ±  29.25  16.33  ±  11.11  21.66  ±  12.36
<60 years  13  (33.3)  21.34  ±  12.86 0.284 18.18  ±  13.61 0.012c 19.15  ±  11.26 0.464
≥60 years 26  (66.7) 30.47  ±  23.63  10.17  ±  4.66  16.12  ±  11.34
a Microvessel density.
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c Signiﬁcant (p < 0.05).
Mean  MVD  ±  SD  was  31.94  ±  18.9  in  the  oral  cavity  and
7.54  ±  20.8  in  the  lower  lip.  The  highest  and  lowest  mean
VD  values  (92.00  and  5.30,  respectively)  were  observed
n  the  oral  cavity  SCC  group.  No  signiﬁcant  difference  was
ound  between  the  lower  lip  and  oral  cavity  (p  =  0.32)
Mean  LVD  ±  SD  in  the  tumoral  tissue  was  13.05  ±  8.2  in
he  oral  cavity  and  16.57  ±  10.79  in  the  lower  lip  SCC  group.
umor  invasive  margin  demonstrated  a  mean  LVD  ±  SD  of
.94  ±  5.59  and  12.50  ±  7.8  in  the  oral  cavity  and  lower  lip,
espectively.  The  highest  and  the  lowest  amounts  of  mean
VD  were  observed  in  the  tumor  front  when  compared  with
he  neoplastic  tissue,  with  the  highest  value  being  48.67
n  an  oral  cavity  tumor  and  the  lowest  counting  0.67  in
he  lower  lip.  Neither  tumoral  tissue  (p  =  0.105)  nor  invasive
ront  (p  =  0.098)  showed  signiﬁcant  differences  between  the
ower  lip  and  oral  cavity.
Comparison  of  MVD  and  LVD  between  oral  cavity  and
ower  lip  SCCs  according  to  age  and  sex  is  shown  in  Table  1.
ased  on  our  results,  lower  lip  SCC  patients  younger  than
0  years  of  age  demonstrated  signiﬁcantly  higher  neoplastic
VD  compared  to  those  older  than  60  years  (p  =  0.012).
iscussion
etastasis  of  malignant  cells  to  lymph  nodes  is  one  of  the
ajor  prognostic  factors  in  many  solid  tumors  like  oral
CC.21 Angiogenesis  and  lymphangiogenesis  provide  new  ves-
els  through  which  malignant  cells  can  leave  the  surrounding
rea  of  the  primary  tumor.13 Different  aspects  of  these  two
rocesses  have  been  evaluated  in  SCC  of  the  oral  cavity  and
ip  using  different  markers.15--18 CD105  is  currently  employed
or  the  evaluation  of  newly  formed  vessels.  This  protein
referably  binds  to  the  active  endothelial  cells  involved  in
he  process  of  angiogenesis.  For  this  reason,  CD105  is  highly
xpressed  in  proliferating  endothelial  cells,  while  its  expres-
ion  is  weak  or  negative  in  normal  vessels.  The  power  and
bility  of  CD105  for  quantitative  differentiation  between
ctive/proliferating  and  normal/quiescent  endothelial  cells
akes  it  possible  to  evaluate  newly  formed  tumor  blood
essels  more  accurately.22,23On  the  contrary,  fewer  studies  have  been  performed  on
ymphatic  vessels  because  of  an  absence  of  appropriate
cular  techniques.  In  the  past,  many  researchers  believed
hat  tumors,  due  to  the  lack  of  lymphatic  vessels,  cannot
t
c
i
induce  lymphangiogenesis.  In  the  recent  decade,  speciﬁc
ntibodies  against  lymphatic  endothelial  cells  have  been
dentiﬁed,  leading  to  a  modiﬁcation  of  the  general  viewpoint
oward  this  process.11 D2-40  is  a  marker  that  is  expressed  on
ndothelial  cells  of  lymphatic  vessels  and  has  been  used  for
he  evaluation  of  LVD  in  recent  years.24 In  the  present  study
e  used  D2-40  and  CD105  to  evaluate  angiogenesis  and  lym-
hangiogenesis  in  SCC  of  the  lower  lip  and  oral  cavity.  Our
esults  showed  higher  MVD  in  the  oral  cavity  compared  to  the
ip,  but  the  difference  was  not  signiﬁcant.  In  agreement  with
ur  ﬁndings,  Ma˘rga˘ritescu  et  al.,25 using  CD-105,  reported  no
igniﬁcant  difference  between  these  sites;  however,  they
ound  MVD  to  be  higher  in  lip  SCCs.  In  contrast,  Oliveira-
eto  et  al.17 demonstrated  signiﬁcant  differences  in  MVD
etween  SCCs  of  the  lip  and  oral  cavity,  with  MVD  being
igher  in  oral  tumors.  Chronic  sun  exposure,  as  seen  in  pho-
oaged  skin,  has  been  suggested  to  decrease  the  number  of
lood  vessels  in  the  upper  dermis,26 while  oral  cavity  mucosa
s  known  for  its  high  vascularity  and  efﬁcient  blood  supply.
his  fact  may  be  responsible  for  the  higher  MVD  of  our  intra-
ral  SCCs.  In  addition,  considering  the  metastasis-promoting
ole  of  angiogenesis,  the  higher  MVD  of  oral  cavity  tumors
n  this  study  is  in  line  with  previous  reports,  stating  that
ral  cavity  tumors  are  more  prone  to  lymph-node  metasta-
is  and  demonstrate  a  lower  survival  rate  when  compared  to
ip  tumors.2,3
Contrary  to  our  MVD  ﬁndings,  the  mean  LVD  in  the  current
nvestigation  was  higher  in  lower  lip  versus  oral  cavity  SCCs;
owever,  like  MVD,  no  signiﬁcant  difference  was  observed
etween  the  sites  in  neither  tumoral  tissue  nor  invasive  mar-
in.  Oliveira-Neto  et  al.17 also  demonstrated  that  the  differ-
nce  in  LVD  between  the  oral  cavity  and  lower  lip  was  not
igniﬁcant;  however,  their  results  showed  a  slightly  higher
VD  in  lip  SCCs  compared  to  oral  cavity  tumors.  In  contrast  to
ur  ﬁndings,  Watanabe  et  al.,18 in  a  sample  of  105  oral  cavity
CCs  and  only  three  cases  of  lip  tumors,  reported  signiﬁ-
antly  higher  mean  LVD  in  lip  versus  oral  cavity  SCCs.  Since
etastasis  to  lymph  nodes  of  SCC  is  more  common  in  the
ral  cavity  than  the  lower  lip  and  lymphatic  vessels  provide
asier  access  to  the  lymphatic  system  for  malignant  cells,
he  mean  LVD  was  expected  to  be  higher  in  oral  cavity  SCCs
ompared  to  lip  tumors,  while  the  opposite  was  observed
n  our  study.  Different  cellular  and  molecular  factors  are
nvolved  in  the  development  and  progression  of  lymphatic
r  lip  
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metastasis,  of  which  lymphangiogenesis  is  only  one  of  them.
Evaluation  of  other  effective  factors  may  better  reveal  the
biologic  differences  between  lower  lip  and  oral  cavity  SCC.
The  statistically  insigniﬁcant  differences  in  both  factors
between  the  lip  and  oral  cavity  observed  in  the  current
investigation  are  comparable  to  previous  studies,  which
found  lip  cancer  to  be  closely  related  to  upper  digestive
tract  malignancies.5 Additionally,  it  is  noteworthy  that  in  all
of  the  abovementioned  studies,  ‘‘lip  specimens’’  included
the  upper  and  lower  lips,  while  we  excluded  upper  lip  SCCs
from  our  study  sample.  Consequently,  our  ﬁndings  reﬂect
MVD  and  LVD  of  lower  lip  tumors  in  comparison  to  oral  neo-
plasms,  and  our  results  therefore  may  not  be  accurately
compared  with  those  investigations.  The  importance  of  the
exclusive  selection  of  lower  lip  SCC  is  reﬂected  in  the  fact
that  they  have  been  shown  to  be  biologically  distinct  from
upper  lip  tumors.  Malignancies  in  these  locations  also  differ
in  prevalence,  and  possibly  in  etiology:  SCC  of  the  lower
lip  is  more  common  than  in  the  upper  lip,  and  the  role
of  UV  light  and  pipe  smoking  is  more  prominent  in  caus-
ing  lower  lip  versus  upper  lip  SCC.19,27 On  the  other  hand,
the  growth  of  lower  lip  malignancy  is  slower  than  its  coun-
terpart,  with  a  better  prognosis.  For  these  reasons,  some
investigators  suggest  that  SCC  of  the  upper  lip  should  be
evaluated  as  a  separate  entity  in  order  to  render  more  reli-
able  results.26--29 Regarding  demographic  data,  we  found  a
signiﬁcantly  higher  neoplastic  LVD  in  patients  with  lower  lip
SCCs  who  were  younger  than  60  years,  as  compared  to  those
who  were  aged  60  or  older.  This  is  in  accordance  with  pre-
vious  studies  demonstrating  an  aggressive  course  of  disease
in  some  young  patients  and  those  indicating  differences  in
the  molecular  proﬁle  of  young  and  old  patients  with  SCC.30
It  should  be  mentioned  that  if  we  had  access  to  TNM  stag-
ing,  survival  and  metastasis  data  of  the  patients,  we  could
comment  on  the  relationship  of  metastasis  with  angiogene-
sis  and  lymphangiogenesis  in  lower  lip  and  oral  cavity  SCC
with  more  certainty.
Final comments
In  recent  years,  studies  performed  on  a  number  of  cel-
lular  and  molecular  markers  in  lip  and  oral  cavity  SCCs
have  revealed  some  differences,  indicating  their  biologic
variations.2,3 On  the  other  hand,  the  expression  of  other
proteins  showed  no  difference  between  these  two  groups.7,8
Based  on  the  results  of  the  current  investigation,  angiogen-
esis  and  lymphangiogenesis  do  not  seem  to  be  helpful  in
clarifying  the  biologic  difference  of  lower  lip  and  oral  cav-
ity  SCC.  It  seems  that  the  search  for  additional  factors  other
than  those  related  to  the  vasculature  should  continue  to  help
clarify  the  differences  in  biologic  behavior  between  lower  lip
and  oral  cavity  SCCs.
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